Editor's Choice
INFECTIOUS DISEASES / PUBLIC HEALTH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Influenza may be correlated with a high number of complications and generate high costs of treatment. The study aimed to estimate the socioeconomic significance of hospitalized influenza cases.

Material and methods:
In the 2015–2016 flu season 157 children (median age 17 months) were hospitalized in the Department of Pediatrics. The diagnosis was confirmed with the rapid influenza diagnostic test (RIDT), polymerase chain reaction (PCR) or both. The study assessed the direct and indirect costs of hospitalization, including the cost of treatment, work absence and the related income lost.

Results:
The frequency of complications among the children hospitalized was 57.3% (90/157), mainly due to pneumonia (31%) and bronchitis (23%). Patients with complications required longer hospital treatment (8 vs. 6 days, p < 0.01) and generated a higher total cost (€ 1042 vs. € 779, p < 0.01), including the patient’s and systemic costs (€123 vs. € 94, p < 0.01 and € 916 vs. € 690, p < 0.01, respectively). Patients with complications had a 3.5-fold higher risk of generating higher (i.e., above median) costs. The difference in the costs between children aged under 2 and those over 2 years old was greater than the difference between children aged under 5 and those over 5 years old (€ 358 vs. € 253).

Conclusions:
Influenza complications generate higher systemic and patient’s costs, both direct and indirect. The group of children for whom the difference is especially marked is under 2 years of age.

 
REFERENCES (25)
1.
Committee on Infectious Diseases. Recommendations for Prevention and Control of Influenza in Children, 2017-2018. doi: 10.1542/peds.2017-2550.
 
2.
Hayward A, Fragaszy EB, Bermingham A, et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med 2014; 2: 445-54.
 
3.
www.pzh.gov.pl [Accessed: 1.03.2017].
 
4.
Hamborsky J, Kroger A, Wolfe S, (eds.). Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Public Health Foundation, Washington D.C. 2015; 261-78.
 
5.
Aguirre E, Papenburg J, Ouakki M, et al. Comparison of pandemic and seasonal influenza in the pediatric emergency department. Pediatr Infect Dis J 2011; 30: 633-9.
 
6.
 
7.
Hryniewicz W, Albrecht P, Radzikowski A. Rekomendacje postępowania w pozaszpitalnych zakażeniach układu oddechowego 2016. Narodowy Instytut Leków, Warsaw 2016; 105-6.
 
8.
Hryniewicz W, Ozorowski T. Rekomendacje diagnostyki, terapii i profilaktyki antybiotykowej w szpitalu. Narodowy Instytut Leków, Warsaw 2015.
 
9.
Koul PA, Mir H, Bhat MA, et al. Performance of rapid influenza diagnostic tests (QuickVue) for influenza A and B Infection in India. Indian J Med Microbiol 2015; 33: 26-31.
 
10.
Zimmerman RK, Rinaldo ChR, Nowalk MP, et al. Detection of influenza virus infection using two PCR methods. Adv Virol 2014: 274679.
 
11.
Tham N, Hang V, Khanh TH, et al. Comparison of the Roche RealTime ready Influenza A/H1N1 Detection Set with CDC A/H1N1pdm09 RT-PCR on samples from three hospitals in Ho Chi Minh City, Vietnam. Diagn Micorbiol Infect Dis 2012; 74: 131-6.
 
12.
Binsaeed AA, Al-Khedhairy AA, Mandil AMA, et al. A validation study comparing the sensitivity and specificity of the new Dr. KSU H1N1 RTPCR kit with real-time RT-PCR for diagnosing influenza A (H1N1). Ann Saudi Med 2011; 31: 351-5.
 
13.
Bender JM, Ampofo K, Gesteland P, et al. Influenza virus infection in infants less than three months of age. Pediatr Infect Dis J 2010; 29: 6-9.
 
14.
Ehlken B, Anastassopoulou A, Hain J, et al. Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany-results of a database analysis from May 2010 to April 2012. BMC Public Health 2015; 15: 578.
 
15.
Lai PL, Panatto D, Ansaldi F, et al. Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. Hum Vaccin 2011; 7: 217-25.
 
16.
Karve S, Misurski D, Herrera-Taracena G, et al. Annual all-cause healthcare costs among influenza patients with and without influenza-related complications: analysis of a United States managed care database. Appl Health Econ Health Policy 2013; 11:119-28.
 
17.
Hryniewicz W, Ozorowski T, Radzikowski A, et al. Rekomendacje postępowania w pozaszpitalnych zakażeniach układu oddechowego 2010. Narodowy Instytut Leków, Warsaw 2010; 53-4.
 
18.
Damm O, Eichner M, Rose MA, et al. Public health impact anc cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. Eur J Health Econ 2015; 16: 471-88.
 
19.
www.stat.gov.pl [Accessed: 1.03.2017].
 
20.
Antonova EN, Rycroft CE, Ambrose CS, et al. Burden of paediatric influenza in Western Europe: a systematic review. BMC Public Health 2012; 12: 968.
 
21.
Muras M, Krajewski J, Nocun, et al. A survey of patient behaviours and beliefs regarding antibiotic self-medication for respiratory tract infections in Poland. Arch Med Sci 2013; 9: 854-7.
 
22.
Haidopoulou K, Goutaki M, Damianidou L, et al. Human bocavirus infections in hospitalized Greek children. Arch Med Sci 2010; 6: 100-3.
 
23.
Rychlik R, Heinen-Kammerer T, Rusche H, Piercy J, Scuffham P, Zöllner Y. Cost-effectiveness of prophylaxis and treatment of influenza. Dtsch Med Wochenschr 2003; 128: 2267-70.
 
24.
Scuffham PA, West PA. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine 2002; 20: 2562-78.
 
25.
Jackowska T. Recommendations for prevention of influenza in children, 2016–2017. Ped Pol 2016; 91: 606-13.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top